HAMMERBECK, DAVID M.,GUY, CYNTHIA A.,LEUNG, SUZANNE SHUKYIN
申请号：
CA2534313
公开号：
CA2534313C
申请日:
2004.08.05
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
Pharmaceutical formulations in an aqueous (preferably, sprayable) formulaitonincluding an immune response modifier (IRM), such as those chosen fromimidazoquinoline amines, tetrahydroimidazoquinoline amines, imidazopyridineamines, 6,7-fused cycloalkylimidazopyridine amines, 1,2-bridgedimidazoquinoline amines, imidazonaphthyridine amines,imidazotetrahydronaphthyridine amines, oxazoloquinoline amines,thiazoloquinoline amines, oxazolopyridine amines, thiazolopyridine amines,oxazolonaphthyridine amines, thiazolonaphthyridine amines, and 1H-imidazodimers fused to pyridine amines, quinoline amines, tetrahydroquinoline amines,naphthyridine amines, or tetrahydronaphthyridine amines, are provided. In oneembodiment, the aqueous formulations are advantageous for treatment and/orprevention of allergic rhinitis, viral infections, sinusitis, and asthma.
